rs145210051
Positions:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_001080414.4(CCDC88C):c.4707G>A(p.Arg1569Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00317 in 1,599,192 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0033 ( 13 hom. )
Consequence
CCDC88C
NM_001080414.4 synonymous
NM_001080414.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.668
Genes affected
CCDC88C (HGNC:19967): (coiled-coil domain containing 88C) This gene encodes a ubiquitously expressed coiled-coil domain-containing protein that interacts with the dishevelled protein and is a negative regulator of the Wnt signalling pathway. The protein encoded by this gene has a PDZ-domain binding motif in its C-terminus with which it interacts with the dishevelled protein. Dishevelled is a scaffold protein involved in the regulation of the Wnt signaling pathway. The Wnt signaling pathway plays an important role in embryonic development, tissue maintenance, and cancer progression. Mutations in this gene cause autosomal recessive, primary non-syndromic congenital hydrocephalus; a condition characterized by excessive accumulation of cerebrospinal fluid in the ventricles of the brain. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.27).
BP6
Variant 14-91279299-C-T is Benign according to our data. Variant chr14-91279299-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 447021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-91279299-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.668 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.00326 (4724/1446914) while in subpopulation MID AF= 0.00887 (51/5750). AF 95% confidence interval is 0.00693. There are 13 homozygotes in gnomad4_exome. There are 2253 alleles in male gnomad4_exome subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 13 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC88C | NM_001080414.4 | c.4707G>A | p.Arg1569Arg | synonymous_variant | 28/30 | ENST00000389857.11 | NP_001073883.2 | |
CCDC88C | XM_011536796.3 | c.4599G>A | p.Arg1533Arg | synonymous_variant | 28/30 | XP_011535098.1 | ||
CCDC88C | XM_047431418.1 | c.4440G>A | p.Arg1480Arg | synonymous_variant | 25/27 | XP_047287374.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC88C | ENST00000389857.11 | c.4707G>A | p.Arg1569Arg | synonymous_variant | 28/30 | 5 | NM_001080414.4 | ENSP00000374507.6 | ||
CCDC88C | ENST00000334448.5 | n.519G>A | non_coding_transcript_exon_variant | 4/6 | 1 | |||||
CCDC88C | ENST00000556726 | c.*541G>A | 3_prime_UTR_variant | 5/7 | 5 | ENSP00000452406.1 | ||||
CCDC88C | ENST00000557455.1 | n.679G>A | non_coding_transcript_exon_variant | 1/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00225 AC: 342AN: 152160Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
342
AN:
152160
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00269 AC: 608AN: 225902Hom.: 1 AF XY: 0.00251 AC XY: 306AN XY: 121890
GnomAD3 exomes
AF:
AC:
608
AN:
225902
Hom.:
AF XY:
AC XY:
306
AN XY:
121890
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00326 AC: 4724AN: 1446914Hom.: 13 Cov.: 30 AF XY: 0.00314 AC XY: 2253AN XY: 718286
GnomAD4 exome
AF:
AC:
4724
AN:
1446914
Hom.:
Cov.:
30
AF XY:
AC XY:
2253
AN XY:
718286
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00225 AC: 342AN: 152278Hom.: 0 Cov.: 32 AF XY: 0.00197 AC XY: 147AN XY: 74464
GnomAD4 genome
AF:
AC:
342
AN:
152278
Hom.:
Cov.:
32
AF XY:
AC XY:
147
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | CCDC88C: BP4, BP7 - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 07, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at